Are digital therapeutics (DTx) the future of mental health care?
Originally presented at the DTx West 2021 Conference on February 25th 2021.
Join Big Health’s Dr. Jenna Carl, VP of Clinical Development and Medical Affairs as she moderates a panel discussion with Dr. Andrew Krystal of UCSF, Dr. Juliette McClendon from Boston University, Dr. Jordan Silberman from Anthem, and Brian Dolan from Exits and Outcomes, on the importance of clinical evidence to the future of digital therapeutics.
Don’t have time to watch the full video? We got your back. Check out our blog highlighting the key takeaways from the panel.
Here’s our latest
Effective strategies for combating youth depression and suicidality in the digital age
As part of Suicide Prevention Awareness Month, Big Health and Vita Health came together with Solome Tibebu of Going Digital:…
Beyond Medication: Changing the Paradigm in Behavioral Health Care
A newly commissioned study conducted by Milliman in the traditional Medicare population found that nearly 70% of anxiety and insomnia…
Navigating the Employee Benefits Ecosystem
Benefits leaders are faced with the unique challenge of expanding access to mental health care by reaching employees in the…